Kiniksa Pharmaceuticals (NASDAQ:KNSA) Raised to Buy at Wall Street Zen
Wall Street Zen upgraded shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) from a hold rating to a buy rating in a research report report published on Saturday morning. A number of other brokerages have also issued reports on KNSA. Citigroup started coverage on Kiniksa Pharmaceuticals in a research report on Thursday, March 13th. They […]
Wall Street Zen upgraded shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) from a hold rating to a buy rating in a research report report published on Saturday morning. A number of other brokerages have also issued reports on KNSA. Citigroup started coverage on Kiniksa Pharmaceuticals in a research report on Thursday, March 13th. They […]
